ArticleThe Journal of urology2015

Risk of diabetes among patients receiving primary androgen deprivation therapy for clinically localized prostate cancer.

Huei-Ting Tsai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.